Radiotherapy and Breast Reconstruction: What Is the Ideal Timing? A Narrative Review.


Journal

Reviews on recent clinical trials
ISSN: 1876-1038
Titre abrégé: Rev Recent Clin Trials
Pays: United Arab Emirates
ID NLM: 101270873

Informations de publication

Date de publication:
2022
Historique:
received: 22 09 2021
revised: 13 11 2021
accepted: 24 12 2021
pubmed: 16 3 2022
medline: 27 10 2022
entrez: 15 3 2022
Statut: ppublish

Résumé

Women undergoing mastectomy choose to pursue breast reconstruction (BR) in order to reduce their body image distress.Adjuvant chest wall irradiation is associated with a negative cosmetic outcome. The aim of our review was to identify the optimal timing of BR relating to radiotherapy delivery. Using Cochrane Library, Embase, PubMed, Springer, Wanfang and CNKI, we performed a non-systematic review of articles published up to August 2021. There is no hard evidence in favor of immediate, delayed or 2-stage BR when post-mastectomy radiation is indicated. Immediate and 2-stage BR seem to be valid alternatives to delayed BR. Further research is essential in order to assess clinician and patient reported aesthetic outcomes and determine the optimal timing of BR in view of post-mastectomy radiotherapy, in breast cancer survivors.

Identifiants

pubmed: 35289255
pii: RRCT-EPUB-121550
doi: 10.2174/1574887117666220314161609
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-85

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Evanthia Letsiou (E)

Medical School, University of Thessaly, 415 00 Larissa, Greece.

Sergios Tsakatikas (S)

Department of Medical Oncology, Metaxa Cancer Hospital, 185 37 Athens, Greece.

George Vakis (G)

Plastic Surgery Clinic, Evangelismos General Hospital, Ipsilantou 45-47, 106 76, Athens, Greece.

Konstantinos Tsapakidis (K)

Department of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500, Larisa, Greece.

Nikolaos Charalampakis (N)

Department of Medical Oncology, Metaxa Cancer Hospital, 185 37 Athens, Greece.

Alexandros Diamantis (A)

Department of Surgery, Medical School, University of Thessaly, 415 00 Larissa, Greece.

Antigoni Poultsidi (A)

Department of Surgery, Medical School, University of Thessaly, 415 00 Larissa, Greece.

Dimosthenis Michelakis (D)

Department of Surgical Oncology, Medical School of Crete University Hospital, 711 10 Heraklion, Greece.

Eelco de Bree (E)

Department of Surgical Oncology, Medical School of Crete University Hospital, 711 10 Heraklion, Greece.

Davide Mauri (D)

Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Department of Medical, Oncology, Greece Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), University Hospital of Ioannina, Ioannina, Greece.

Nikolaos Tsoukalas (N)

Department of Oncology, 401 General Military Hospital of Athens, 115 25, Athens, Greece.

Chrysostomos Antoniades (C)

Department of Radiotherapy, School of Medicine, University of Crete, 711 10, Heraklion, Greece.

Maria Tolia (M)

Department of Radiotherapy, School of Medicine, University of Crete, 711 10, Heraklion, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH